Invention Grant
- Patent Title: Malaria immunogen and methods for using same
-
Application No.: US17628640Application Date: 2020-07-24
-
Publication No.: US12161710B2Publication Date: 2024-12-10
- Inventor: Bryce Chackerian , David S. Peabody , Nikolai Petrovsky , Lucia Jelinkova , Fidel Zavala
- Applicant: Bryce Chackerian , David S. Peabody , Lucia Jelinkova , UNM RAINFOREST INNOVATIONS , THE JOHNS HOPKINS UNIVERSITY , VAXINE PTY LTD.
- Applicant Address: US NM Albuquerque; US NM Albuquerque; US NM Albuquerque; US NM Albuquerque; US MD Baltimore; AU Bedford Park
- Assignee: Bryce Chackerian,David S. Peabody,Lucia Jelinkova,UNM RAINFOREST INNOVATIONS,THE JOHNS HOPKINS UNIVERSITY,VAXINE PTY LTD.
- Current Assignee: Bryce Chackerian,David S. Peabody,Lucia Jelinkova,UNM RAINFOREST INNOVATIONS,THE JOHNS HOPKINS UNIVERSITY,VAXINE PTY LTD.
- Current Assignee Address: US NM Albuquerque; US NM Albuquerque; US NM Albuquerque; US NM Albuquerque; US MD Baltimore; AU Bedford Park
- Agency: MUETING RAASCH GROUP
- International Application: PCT/US2020/043375 WO 20200724
- International Announcement: WO2021/016509 WO 20210128
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/12 ; A61P33/06 ; C07K14/005 ; C12N7/00 ; A61K38/00
Abstract:
An immunogen useful for treating malaria generally includes an immunogenic carrier and an antigenic malaria circumsporozoite protein (CSP) peptide that includes the peptide NPDPNANPNVDPNAN (amino acids 5-19 of SEQ ID NO:1) linked to the immunogenic carrier. The immunogen may be administered to a subject having or at risk of having malaria.
Public/Granted literature
- US20220280632A1 MALARIA IMMUNOGEN AND METHODS FOR USING SAME Public/Granted day:2022-09-08
Information query
